Detalles de la búsqueda
1.
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer.
Oncologist
; 25(6): 479-e899, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31594913
2.
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors.
Oncologist
; 25(7): 560-e1006, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31876334
3.
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
Semin Cancer Biol
; 47: 177-184, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28823497
4.
Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.
Cells Tissues Organs
; 203(2): 128-138, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28214895
5.
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.
Cancer Immunol Immunother
; 63(12): 1307-17, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25186612
6.
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Int J Cancer
; 133(3): 624-36, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23364915
7.
An Interleukin-15 Superagonist Enables Antitumor Efficacy of Natural Killer Cells Against All Molecular Variants of SCLC.
J Thorac Oncol
; 18(3): 350-368, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410696
8.
Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis.
J Immunother Cancer
; 11(9)2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37678915
9.
Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment.
Future Oncol
; 8(6): 713-22, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22764769
10.
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
J Immunother Cancer
; 10(6)2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764364
11.
Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-ß signaling enables PD-L1-mediated tumor eradication.
J Clin Invest
; 132(8)2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35230974
12.
A rare insight into the immunosuppressive landscape of prostate cancer bone metastases.
Cancer Cell
; 39(11): 1450-1452, 2021 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34752752
13.
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression.
Pharmacol Ther
; 219: 107692, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32980444
14.
Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy.
Cancers (Basel)
; 13(5)2021 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33669155
15.
Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy.
Cancers (Basel)
; 13(16)2021 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439097
16.
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).
J Immunother Cancer
; 9(3)2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33762322
17.
T Cell-Mediated Antitumor Immunity Cooperatively Induced By TGFßR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer.
Mol Cancer Ther
; 20(10): 1926-1940, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376576
18.
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.
J Immunother Cancer
; 9(9)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34479925
19.
New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.
Cancer Immunol Immunother
; 59(1): 63-71, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19495750
20.
Vaccines against human carcinomas: strategies to improve antitumor immune responses.
J Biomed Biotechnol
; 2010: 380697, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20300434